{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:14:15Z","timestamp":1771636455952,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.diabres.2008.01.019","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T05:40:43Z","timestamp":1205905243000},"page":"e7-e8","source":"Crossref","is-referenced-by-count":14,"title":["Heparin-induced hyperkalemia"],"prefix":"10.1016","volume":"80","author":[{"given":"C.M.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Smeeton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.A.","family":"Leatherdale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2008.01.019_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00002060-200001000-00019","article-title":"Heparin-induced hyperkalemia confirmed by drug rechallenge","volume":"79","author":"Orlando","year":"2000","journal-title":"Am. J. Phys. Med. Rehab."},{"key":"10.1016\/j.diabres.2008.01.019_bib2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9343(99)80017-5","article-title":"Heparin-induced aldosterone suppression and hyperkalemia","volume":"98","author":"Oster","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.diabres.2008.01.019_bib3","first-page":"446","article-title":"Heparin-induced hyperkalemia; prospective study","volume":"29","author":"Gonz\u00e1lez-Martin","year":"1991","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.diabres.2008.01.019_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/00325481.1990.11704598","article-title":"Heparin-induced hyperkalemia","volume":"87","author":"Edes","year":"1990","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.diabres.2008.01.019_bib5","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/bmj.300.6737.1437","article-title":"Low mol wt heparins and hypoaldosteronism","volume":"300","author":"Levesque","year":"1990","journal-title":"BMJ"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882270800048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882270800048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T22:57:55Z","timestamp":1546210675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882270800048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S016882270800048X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2008.01.019","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}